Abstract
Objective: This study compares the clinical effect of uterine artery chemoembolization (UACE) and uterine artery embolization (UAE) in treating cesarean scar pregnancy. Methods: 71 patients who were diagnosed with cesarean scar pregnancy (CSP) at the First Hospital of Shanxi Medical University between January 2007 and May 2016 were enrolled in this study. These patients were divided into two groups: Group A (33) and Group B (38). Group A received UACE prior to curettage 24-48 hours later while Group B received UAE prior to curettage 24-48 hours later. The hemorrhage volume during the curettage, the time for β-HCG reduced to normal and hospital stays were compared between the two groups. Results: Both groups received satisfactory results. The bleeding during the curettage was recorded as - Group A (40±30) ml, Group B (50±20) ml, thus, there was no significant statistical difference. The time for β-HCG reduced to normal: Group A (16±3) d was less than Group B, which was (21±5 ) d, there was a statistical difference . Hospital stays: Group A (11±3) d also had less stays than Group B (13.5±4.5) d, as showed a statistical difference. Conclusions: UACE and UAE did not have statistical significance in terms of bleeding during curettage and success rate, however, UACE can shorten the time of β-HCG reduced to normal and hospital stays. Key words: Cesarean scar pregnancy; Uterine artery embolization; Uterine artery chemoembolization; Chorionic gonadotropin, beta subunit, human; Methotrexate
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
